Financial toxicity from newly approved second‐/third‐line agents in metastatic urothelial carcinoma

Saved in:
Bibliographic Details
Published in:BJU international 2023-06, Vol.131 (6), p.691-693
Main Authors: Benjamin, David J., Lythgoe, Mark P., Rezazadeh, Arash
Format: Article
Language:English
Subjects:
Antineoplastic Combined Chemotherapy Protocols
Bladder cancer
Carcinoma, Transitional Cell - drug therapy
Carcinoma, Transitional Cell - pathology
Financial Stress
Humans
Metastases
Toxicity
Urinary Bladder Neoplasms - drug therapy
Urinary Bladder Neoplasms - pathology
Urologic Neoplasms - drug therapy
Urologic Neoplasms - pathology
Urothelial carcinoma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1464-4096
1464-410X
DOI:10.1111/bju.16003